Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-23

Clinical Trial Update: Human Bioequivalence Study of Liposomal Amphotericin B for Injection [NA]

View source ↗

Summary

This document reports a human bioequivalence study of liposomal amphotericin B for injection that is currently active but not recruiting, sponsored by Sichuan H…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Liposomal Amphotericin B for Injection (liposomal amphotericin B)

Snippet

Sponsor: Sichuan Huiyu Pharmaceutical Co., Ltd | Conditions: Invasive Fungal Infections, Neutropenic Fever | NA | Status: ACTIVE_NOT_RECRUITING